Development of a best-practice clinical guideline for the use of bleomycin in the treatment of germ cell tumours in the UK

Bleomycin, a cytotoxic chemotherapy agent, forms a key component of curative regimens for lymphoma and germ cell tumours. It can be associated with severe toxicity, long-term complications and even death in extreme cases. There is a lack of evidence or consensus on how to prevent and monitor bleomyc...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Br J Cancer
Main Authors: Watson, Robert A., De La Peña, Hugo, Tsakok, Maria T., Joseph, Johnson, Stoneham, Sara, Shamash, Jonathan, Joffe, Johnathan, Mazhar, Danish, Traill, Zoe, Ho, Ling-Pei, Brand, Sue, Protheroe, Andrew S.
Formato: Artigo
Idioma:Inglês
Publicado em: Nature Publishing Group UK 2018
Assuntos:
Consensus Statement
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC6219480/
https://ncbi.nlm.nih.gov/pubmed/30356125
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/s41416-018-0300-x
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados